Artal Participations S.a r.l 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-12 6:17 pm Sale | 2024-07-12 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal Participations S.a r.l | 116,155 4.300% | -22,800 (-16.41%) | Filing |
| 2024-02-09 5:06 pm Sale | 2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal Participations S.a r.l | 138,955 5.700% | -1 (-0.00%) | Filing |
| 2022-02-11 06:35 am Purchase | 2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal Participations S.a r.l | 138,956 6.400% | 48,077 (+52.90%) | Filing |
| 2021-02-12 8:55 pm Sale | 2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal Participations S.a r.l | 90,879 5.400% | -2,200 (-2.36%) | Filing |